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Abstract
Introduction The outcome of patients who are scheduled
for gastrointestinal surgery is influenced by various factors,
the most important being the age and comorbidities of the
patient, the complexity of the surgical procedure and the
management of postoperative recovery. To improve patient
outcome, close cooperation between surgeons and anaes-
thesiologists (joint risk assessment) is critical. This coop-
eration has become increasingly important because more
and more patients are being referred to surgery at an
advanced age and with multiple comorbidities and because
surgical procedures and multimodal treatment modalities
are becoming more and more complex.
Objective The aim of this review is to provide clinicians
with practical recommendations for day-to-day decision-
making from a joint surgical and anaesthesiological point of
view. The discussion centres on gastrointestinal surgery
specifically.
Keywords Perioperative management.Risk assessment.
Gastrointestinal surgery.Practical recommendations
Introduction
The outcome of patients who undergo gastrointestinal surgery
varies greatly. Factors such as the patient’s age and comorbid-
ities, the complexity of the surgical procedure and the
management of postoperative recovery influence the outcome
[1, 2]. Modern perioperative management has been improved
in numerous ways over the last decade and nowadays is
regarded as a highly multidisciplinary task (Fig. 1). Because
an ageing population is leading to more and more patients
with multiple comorbidities being referred to surgery and
because surgical procedures and multimodal treatment modal-
ities are becoming increasingly complex, close cooperation
between surgeons and anaesthesiologists (i.e. joint risk
assessment) is critical for improving outcome after major
gastrointestinal surgery. Internists are also frequently involved
to optimise the patient’s physical condition or medication.
It is beyond the scope of this review to comprehensively
summarise the body of literature on perioperative management.
Rather, we aim to provide clinicians with practical recommen-
dations from a joint surgical and anaesthesiological point of
view, with a specific emphasis on nonemergency gastrointes-
tinal surgery. Because adequately powered randomised clinical
trials are often lacking, some of these recommendations and
suggestions are more empirical than evidence based. In
addition, these recommendations partially represent the day-
to-day practice at our University Medical Center.
Preoperative management
Medical history and clinical assessment
A detailed medical history and a thorough clinical
assessment of the patient’s physical and psychological
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identify patient risk factors for imminent morbidity or
mortality (e.g. an unappreciated reduction of physical
fitness, specific medications or newly developed medical
illness). Ideally, the medical history is taken, and the
assessment performed before the patient’s admission to
the hospital so that certain medical conditions can be
optimised (e.g. stabilisation of chronic heart failure, poorly
controlled diabetes mellitus or arterial hypertension).
However, when surgery is required for a gastrointestinal
malignancy, a thorough pre-admission assessment may not
be wise because it could substantially delay surgery.
Routine diagnostic tests
Close interaction between surgeons and anaesthesiologists
is critical for improving patient outcome after major
gastrointestinal surgery, and risk assessment should always
be joint. There are routine test results that should be
available before the patient is referred to anaesthesiology
consultation (modified from [3]).
Laboratory tests
Preoperative laboratory testing should be performed for all
patients prior to gastrointestinal surgery. At minimum, the
testing should consist of:
& Standard blood count
& International normalised ratio
& Activated partial thromboplastin time (aPTT)
& Concentrations of sodium, potassium, creatinine and
glucose
Certain procedures or clinical conditions may require
additional assessments. Occasionally, a laboratory test
may be required on the day of surgery (e.g. serum
potassium levels after extensive mechanical bowel prepa-
ration (MBP) or glucose levels for patients with severe
diabetes mellitus). Recent data have indicated that an
elevated preoperative level of brain natriuretic peptide is
associated with increased cardiac morbidity after major
surgery, but it remains to be seen whether this level will be
routinely determined for patients with cardiac risk factors
[4–6].
Electrocardiography
Preoperative 12-channel electrocardiography (ECG) allows
for screening of as-yet undetected cardiac disorders. It also
serves as a control should perioperative cardiac complica-
tions occur. ECG should be performed for patients who:
& Are >40 years old
& Have relevant cardiac disorders (e.g. coronary artery
disease, heart insufficiency, heart rhythm disturbances
or valve disorders)
& Have a pacemaker (PM) or implanted cardioverter/
defibrillator (ICD)
& Have newly developed pulmonary or cardiac symptoms
& Are receiving preoperative chemotherapy or
chemoradiotherapy
Although it is not routine practice, many clinicians
recommend that for patients with coronary artery disease
who underwent high-risk surgery, an additional ECG
should be obtained immediately after surgery as well as
on days 1 and 2 postoperatively.
Fig. 1 Basic principles of
modern perioperative
management to improve
patient outcome after major
gastrointestinal surgery
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The sensitivity of conventional chest radiography to
detect pathophysiologic conditions in asymptomatic
patients is relatively low. However, X-ray images may
always serve as a basis for comparison should perioper-
ative complications occur. While there is currently no
recommendation for preoperative chest radiography for
patients with an American Society of Anesthesiologists
score 1–2, regardless of the patient’s age, it is indicated
for patients who:
& Suffer from severe chronic obstructive pulmonary
disease
& Developed yet unknown pulmonary or cardiac
symptoms
& Have gastrointestinal malignancies (screening for
pulmonary metastases)
Advanced diagnostic tests
After reviewing the results of routine diagnostic tests, the
anaesthesiologist will likely request additional tests for
certain patients or certain medical conditions (modified
from [3]). Although not indicated for standard gastrointes-
tinal surgery, these additional tests can help in the
assessment of the potential risk for perioperative problems
and complications.
Echocardiography
Preoperative echocardiography should be performed on
patients who:
& Have newly occurring dyspnoea of unknown origin
& Have known heart insufficiency with symptoms of
deterioration
& Have cardiomyopathy and have undergone preoperative
chemotherapy with epirubicin (see “Chemotherapy and
chemoradiotherapy” below)
Carotid Doppler ultrasonography
Preoperative carotid Doppler ultrasonography should be
performed on patients who:
& Had experienced transient ischemic attack (TIA) or
stroke within the preceding 3 months if the episode had
occurred without proper follow-up medical assessment
or diagnosis
& Had experienced TIA or stroke within the preceding
3 months if symptoms of deterioration have
appeared
Preoperative risk assessment
Definition of “high risk”
The definition of being “high risk” for poor outcome after
surgery is nebulous, as it is influenced by many variables that
vary from patient to patient and from one surgical procedure to
another [7]. The surgeon and anaesthesiologist need to jointly
evaluate the potential perioperative risk for each patient and
the intended procedure. Relevant clinical conditions that
characterise high-risk surgical patients are listed in Table 1,
and the top 10 clinical variables that influence 30-day and
long-term mortality are highlighted in Table 2 (modified from
Ackland and Edwards [7] and Khuri et al. [8]).
Risk scores
In an attempt to facilitate perioperative risk assessment, a
variety of scoring systems have been developed that incorpo-
rate the patient’s age and comorbidities and the complexity of
the surgical procedure. Well-known systems include the
Physiological and Operative Severity Score for the Enumer-
ation of Mortality and Morbidity [9] and the Estimation of
Physiologic Ability and Surgical Stress score [10]. However,
both systems indicate a general risk for complications and do
not specify or pinpoint any specific complication. Accord-
ingly, their implementation into routine clinical practice has
proven to be difficult. Data from our University Medical
Center suggest that the subjective opinion (“gut feeling”)o f
the surgeon is a good predictor of postoperative outcome,
especially in nonemergency surgery [11].
More recently, a risk calculator for colorectal surgery has
been developed by the National Surgical Quality Improve-
ment Program registry of the American College of
Surgeons. After a patient's variables are entered, the risk
probabilities for adverse outcome are calculated [12].
However, only registry members can access the calculator,
and it is not clear whether this US hospital-based tool is
applicable to European institutions.
Cardiac risk evaluation
Overall, gastrointestinal surgery is associated with a
medium cardiac risk [13–16]. However, due to an ageing
Table 1 Clinical conditions that characterise high-risk surgical
patients undergoing major gastrointestinal surgery
Coronary artery disease
Heart insufficiency
Renal failure
Poorly controlled diabetes mellitus
Older age
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disease and the increasing complexity of surgical proce-
dures, postsurgical cardiac complications are now a leading
cause of morbidity and mortality. Particularly cardiac
insufficiency is emerging more and more as a risk factor
for perioperative adverse outcome, even compared with
cardiac ischemia [17]. Comorbidities that increase the
cardiac risk for patients undergoing gastrointestinal surgery
include:
& Coronary artery disease
& Heart insufficiency
& Severe aortic stenosis
& Peripheral artery disease
& Cerebrovascular insufficiency
& Renal failure
& Diabetes mellitus
Because both the assessment of these cardiac risk factors
and their clinical interpretation are complicated, patients
with diverse cardiac risk factors, acute symptoms of a
cardiac disease or reduced physical fitness should be
referred for consultation with an experienced cardiologist
[13–16].
Pulmonary risk evaluation
Late postoperative pulmonary complications are the
second-leading cause of morbidity and mortality after
major surgery. For this reason, preoperative optimisation
of the patient’s physical condition and medication is
important. Clinical parameters that represent risk factors
for pulmonary complications after gastrointestinal surgery
are listed in Table 3 (modified from [18, 19]). Although
most of these risk factors cannot be circumvented, they
must be kept under consideration [20].
Medication
Because the abrupt discontinuance of certain drugs may
cause severe problems, a detailed medical history of the
patient’s medication is very important. In general, cardio-
vascular medication should be continued. Clear liquid
intake (e.g. water or tea but not milk) is allowed until 2 h
before anaesthesia, and solid food intake is recommended
for up to 6 h prior to anaesthesia, so continuing medication
usually does not create problems.
Beta-adrenergic blockers
Beta-adrenergic blockers are frequently used in the peri-
operative management of patients with cardiac disease due
to their favourable effect on the supply and demand ratio of
myocardial oxygen. Although still under debate, it is
currently recommended that all patients who are already
receiving beta-adrenergic blockers continue them perioper-
atively [14, 21]. Abrupt discontinuation can cause unstable
angina, tachyarrhythmia, myocardial infarction and sudden
death. If a patient who is scheduled for elective gastroin-
testinal surgery requires a new prescription, it should be
started at least 1 month before the procedure to allow for
dose adjustment [14, 21].
Diuretics
Diuretics should not be used on the day of surgery because
this may increase the risk of intraoperative hypovolaemia.
Table 3 Clinical parameters that represent risk factors for pulmonary
complications after gastrointestinal surgery
Patient-related factors
Congestive heart failure
ASA score ≥2
Age >60 years
COPD
Functional dependence
Procedure-related factors
Abdominal surgery
Thoracic surgery
Surgery lasting >3 h
Emergency surgery
General anaesthesia
Laboratory-test-related factors
Serum albumin concn <3.0 g/dl
ASA American Society of Anaesthesiologists; concn concentration;
COPD chronic obstructive pulmonary disease
Table 2 Top 10 clinical conditions that influence 30-day mortality
and long-term mortality after major gastrointestinal surgery
30-Day mortality Long-term survival
Any complication Older age
ASA class Albumin concn (g/dl)
Emergency surgery Any complication
Albumin concn (g/dl) ASA class
RBC units transfused
intraoperatively
Blood urea nitrogen
concn >40 mg/dl
Older age COPD
Sodium concn <135 nmol/l Smoking
Disseminated cancer Diabetes
Blood urea nitrogen concn
>40 mg/dl
Functional status
SGOT >40 IU/ml Disseminated cancer
ASA American Society of Anaesthesiologists; concn concentration;
COPD chronic obstructive pulmonary disease; RBC red blood cells;
SGOT serum glutamic oxaloacetic transaminase
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continued postoperatively, especially for patients who have
heart failure.
Metformin
The relevance of the oral anti-diabetic drug metformin for
inducing lactic acidosis has been controversially discussed
in the literature [22]. Regardless, it is recommended that its
intake be stopped 48 h prior to the surgery.
Acetylsalicylic acid and thienopyridine derivatives
Anti-platelet therapy (usually 100 mg of acetylsalicylic acid
daily) is standard for most patients with coronary artery
disease. The 2009 European Society of Cardiology guide-
lines suggest that to reduce the risk of stent thrombosis and
myocardial infarction, patients with a coronary bare metal
stent (BMS) or a drug-eluting stent (DES) should receive
anti-platelet therapy with both acetylsalicylic acid and a
thienopyridine derivative (i.e., clopidogrel or ticlopidine)
for 1 month (BMS) or 12 months (DES) after stent
placement [14].
For patients who currently receive anti-platelet therapy
and are scheduled for gastrointestinal surgery, the following
wait times until surgery are recommended:
& After percutaneous transluminal coronary angioplasty
without stent implantation: 2 weeks
& After BMS implantation: 6 weeks, but 3 months
preferred
& After DES implantation: 1 year
For high-risk cardiac patients (i.e. patients with recent
acute coronary syndrome, recurrent angina pectoris or
recent surgical and conservative coronary intervention)
who require major surgery that cannot be postponed,
thienopyridine derivatives should be stopped 7–10 days
before the surgery, whereas acetylsalicylic acid should be
continued during the entire perioperative period [14, 23–
25]. This recommendation also applies to patients who
require an epidural catheter.
L-Dihydroxyphenylalanine
L-Dihydroxyphenylalanine is the most frequently pre-
s c r i b e dd r u gf o rP a r k i n s o n ’s disease. Because of its
relatively short half-life, it should be continued during the
entire perioperative period, as interrupting the medication
can result in a life-threatening complication known as
neuroleptic malignant-like syndrome, which is associated
with fever, confusion and elevated concentrations of muscle
enzymes [26].
Pacemaker or implantable cardioverter/defibrillator
An increasing number of patients who are referred to
surgery have a PM or ICD. For these patients, the
respective PM/ICD pass must be available to health care
providers at any time during the patient’s hospital stay.
Potential electromagnetic interferences during surgery
require certain safety arrangements for the patient (Table 4).
Unfortunately, evidence-based and uniformly accepted
guidelines are lacking, and the large number of manufac-
turers and systems makes general safety recommendations
extremely difficult [13, 27–29].
Mechanical bowel preparation
More than 10 years ago, Kehlet et al. first described a
multimodal programme of enhanced postoperative recovery
for elective surgery [30]. The basis of this fast-track
methodology is the stepwise combination of single-
modality, evidence-based interventions [30–32] (for a more
comprehensive review, please read the accompanying
article “fast track perioperative management: physiologic
principles”). A major intervention principle of this approach
is the avoidance of MBP, particularly for patients undergoing
elective colon surgery [33].
The mechanistic rationale for MBP prior to gastrointes-
tinal surgery is to clean the large bowel of faeces, thereby
Table 4 Safety recommendations for patients with a PM or ICD who
are undergoing gastrointestinal surgery
Recommendations for patients with a PM
Bipolar diathermy should always be the method of choice, as
monopolar electrodes frequently induce interference. An ultrasonic
scalpel is an alternative.
If monopolar diathermy is necessary, the neutral electrode should be
placed as far away from the ICD system as possible, and the use of
diathermy within a 15-cm diameter of the system should be avoided.
Short bursts of low energy with intermitting short breaks should be
used.
A preoperative system check is recommended if the last one had
occurred >1 year previously.
For patients who are PM dependent (permanent PM stimulation), an
alternative external stimulation must be available.
A magnet should be available in case of PM malfunction.
Postoperative PM control is recommended if diathermy was used too
close to the PM system. It is necessary if the system was
reprogrammed preoperatively or if perioperative defibrillation
occurred. The control should be performed in the anaesthetic
recovery room or at the intensive care unit.
Additional recommendations for patients with an ICD
Preoperatively, the antitachycardia function of the ICD should be
switched off and the availability of an external defibrillator ensured.
A magnet should be available to disable the antitachycardia function
of the ICD.
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resection and protecting a colorectal anastomosis. However,
several prospective randomised trials have demonstrated
that the outcome of patients who are scheduled for
colorectal surgery is not significantly different for those
who undergo MBP and those who do not [34–38]. In
addition, extensive MBP may induce abdominal discom-
fort, nausea and pain; it may impair postoperative oral
nutrition, and it may result in electrolyte imbalance and
dehydration [39]. For these reasons, extensive MBP is not
recommended any more.
The fast-track approach, however, is based primarily on
open colorectal surgery, and it remains to be demonstrated
whether avoidance of MBP can be directly translated into the
laparoscopic setting, which is becoming more common for
elective colorectal surgery. In addition, recent data from the
FrenchResearchGroupofRectalCancerSurgeryIIItrialhave
indicated a higher risk of overall and infectious morbidity for
patients who undergo rectal cancer surgery without MBP than
withMBP,suggestingthatthisprocedurebeperformedbefore
elective rectal cancer surgery [40].
Our University Medical Center’s approach to MBP is to
perform preoperative enema on every patient scheduled for
major gastrointestinal surgery. Moderate MBP (1 to 2 l of
polyethylene glycol) is recommended for certain surgical
procedures, particularly rectal surgery.
Other preoperative considerations
Smoking
Because it creates cardiac stress, smoking increases the risk
for perioperative complications, particularly for elderly
patients with impaired cardiac function [41]. For this
reason, systematic smoking intervention is highly recom-
mended. To be of benefit, however, smoking cessation
needs to occur several weeks prior to the surgery [42, 43].
Nutritional support
Although the exact clinical definition of malnutrition has
not been established, it is well documented that poorly
nourished patients are more likely to develop postoperative
complications than well-nourished patients [44–46]. Ac-
cordingly, preoperative enteral and parenteral nutritional
support has been recommended for malnourished patients
[47, 48]. For the general patient population, there is no
evidence for preventive nutritional support.
Obesity
Obesity increases the rate of perioperative complications,
increases morbidityand mortality aftercolectomy [49] and is a
risk factor for postoperative intra-abdominal infection after
gastrectomy [50]. In a recent study of obese patients who
underwent Roux-en-Y bypass or laparoscopic adjustable
gastric banding, 4.3% developed a major adverse outcome
within 30 days [51]. For those patients, a history of deep-vein
thrombosis or pulmonary embolus, a diagnosis of obstructive
sleep apnoea and impaired functional status represented
independent risk factors for perioperative complications.
Chemotherapy and chemoradiotherapy
Due to the increasing complexity of modern concepts on
cancer treatment, an increasing number of patients are
receiving preoperative chemotherapy, either alone or with
irradiation. Clinicians should be aware of four common side
effects of frequently used chemotherapeutic agents and of
radiotherapy. First, the anthracycline epirubicin, which is
used to treat locally advanced gastric cancer, increases the
risk for cardiomyopathy and heart failure, particularly
among elderly patients with pre-existing cardiac disease
[52]. Consequently, cancer patients with cardiomyopathy
who received preoperative chemotherapy with epirubicin
should be considered for a routine echocardiography, in
addition to conventional electrocardiography, prior to any
surgical procedure [53]. Second, the pyrimidine analogue 5-
fluorouracil, the most frequently used chemotherapeutic
agent for gastrointestinal cancer, can induce coronary
vasospams, myocardial ischemia and subsequent infarction
[52]. Third, patients with gastrointestinal malignancy who
receive the topoisomerase I inhibitor irinotecan are at risk
for diarrhoea-induced malnutrition [52]. Fourth, radiother-
apy is a cardiac risk factor for patients with cancer of the
lower oesophagus or the gastroesophageal junction, and
irradiation of rectal cancer can cause severe enteritis,
malabsorption and diarrhoea [54, 55].
Intraoperative management
Prophylactic antibiotics
Preoperative prophylaxis
The goal of preoperative antimicrobial prophylaxis is to
reduce the intraoperative bacterial load to a degree that can
be controlled by the patient’s innate immune system. The
importance of adequate antimicrobial prophylaxis in pre-
venting surgical site infection (SSI) is illustrated by its
inclusion in World Health Organisation’s surgical safety
checklist and by the results of two trials of the use of such a
list [56, 57]. Even so, there are many questions to be
answered and improvements to be realised before the
optimal effect of this intervention can be achieved.
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concentration is known for most antibiotic agents, very
little is known about the time to achieve an adequate
concentration on the skin or in other organs. In addition, the
changes in haemodynamics caused by induction of anaes-
thesia and by the effects of any underlying disease might
influence this timing. Intravenously applied beta-lactam
antibiotics, which are commonly used as SSI prophylaxis,
normally reach peak plasma concentration soon after their
application, but their distribution to tissues depends on
organ perfusion, plasma binding rate, molecular size and
other factors. Studies by Stone and Classen have suggested
that application should occur between 2 and 1 h before the
skin incision [58, 59], and the World Health Organisation
checklist advocates a 1-h interval (the commonly used 30-
min interval has never been rigorously investigated). Other
studies have demonstrated that extension beyond 24 h
actually leads to the emergence of resistant bacteria and
higher rates of SSI [60].
Other issues in optimising the use of preoperative
prophylactic antibiotics include the choice of drug in
relation to the site and type of surgery, adequate dosing,
early identification of potential additional patient risk
factors and local characteristics of bacterial resistance. The
surgical site will determine whether both Gram-negative
and Gram-positive bacteria should be covered. The fre-
quently used cephalosporins, for example, lose their Gram-
positive potency from generation to generation, whereas
their Gram-negative potency increases (although this is not
true for fifth-generation cephalosporins such as ceftobi-
prole, which recover their effectiveness against Gram-
positive germs). Cefazolin is suitable if preventing infection
of the skin and deeper soft tissue (i.e. fascial and muscular
layers) is the main goal. Third-generation cephalosporins
are appropriate for inhibiting infection of the abdominal
cavity organs or space. Third-generation ceftriaxon has a
high permeability into tissues and a high plasma protein
binding rate, which lead to a long plasma half-life of up to
8 h. In contrast, second-generation cefotiam has a plasma
half-life of 30 min and, therefore, is not adequate as a
single-dose perioperative prophylaxis if the time to wound
closure will exceed 1 h. In cases where the surgical
intervention exceeds the plasma half-life of the chosen
antibiotic drug, a second dose after 3 h may be considered
[61].
The risk of developing SSI in developed countries is
very low, around 1% to 3% for clean surgery, but there is
no question that this rate can be significantly reduced [62].
The drugs used should be defined in advance for each
intervention, including alternatives should the patient have
any contraindication against the first-choice antibiotics.
Although it can be applied in the operating room, the drug
is ideally applied beforehand. Application should be started
immediately after intravenous access has been established
(between 2 and 0.5 h before skin incision, as most
antibiotics should reach a relevant tissue level in that time
frame). If the institution carries a holding area, application
might take place there; the “time out” of the surgical
checklist should ensure the antibiotic was given within the
appropriate time frame.
Any application of antimicrobial drugs after closure of
the surgical wound should not be considered perioperative
prophylaxis, as this categorisation thwarts the rationale
behind the approach. Application after wound closure
actually increases the risk of SSI fivefold and promotes
the development of resistant bacterial strains [59, 63]. Even
correctly performed “single-shot” perioperative antibiotic
prophylaxis can induce severe Clostridium difficile infec-
tions and diarrhoea with highly virulent strains [64, 65].
Besides their negative and sometimes life-threatening
consequences, SSIs significantly increase the length of the
hospital stay and the associated costs. Because studies
providing a high level of evidence for the how and when of
perioperative antimicrobial prophylaxis are lacking, much
research is still needed on the optimal and adequate use of
well-established measures, including perioperative antimi-
crobial therapy, to reduce the incidence of SSI. Until then,
the practical approach should be oriented along the
theoretical rationale behind this intervention.
MRSA
There is an ongoing discussion about whether antibiotic
prophylaxis should cover resistant bacterial strains, such as
methicillin-resistant Staphylococcus aureus (MRSA), if the
patient had been colonised before the surgery [66]. The data
do not support the general use of perioperative prophylaxis
with agents active against MRSA if the patient is colonised
by resistant bacteria. Two small studies of hospitals with a
high prevalence of MRSA demonstrated conflicting results
for a cohort of cardiac surgery and neurosurgery patients
[67, 68]. The study in cardiac surgery patients did not
demonstrate a difference in the rate of surgical wound
infections when comparing vancomycin with cefazolin,
whereas the same approach significantly reduced shunt
infections and mortality when neurosurgical patients were
studied. However, for patients at high risk of SSI, who
should be identified in advance of surgery, the extension of
antibiotic prophylaxis to agents against MRSA and other
resistant bacterial strains might be considered.
At our University Medical Center, vancomycin is not the
drug of choice for such cases because it has a high
molecular weight and penetrates poorly into tissues.
Clindamycin, rifampicin or fosfomycin might be used as
long as the MRSA strain is sensitive to these agents;
linezolid and daptomycin are additional options.
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The determination of the most effective use of preoperative
and perioperative antimicrobial therapy for a patient
requires efforts by a multidisciplinary team, including
pivotally the anaesthesiologist and the surgeon but also
the microbiologist and the nursing staff. These efforts will
often require the use of a standard protocol, quality
management and change. The change includes altered
behaviour by surgeons and the other team members
involved in the patient’s care pathway through the surgical
procedure and recovery [69, 70]. Quality improvement
measures from industry have been successfully applied to
hospital settings to achieve adequate, if not optimal,
prophylactic antibiotic use [71].
Measures for avoiding postoperative complications
Major abdominal surgery per se represents a challenge for
the human immune system and other systems needed for a
body to adequately react to surgical stress and to maintain
or restore homeostasis. In general, the degree to which the
stress response of the human body will be controlled during
surgery determines the body’s susceptibility to minor or
major postoperative complications. Measures performed to
induce and maintain surgical anaesthesia can also challenge
these systems. From a large range of potential interventions
for ameliorating postoperative complications, this review
focuses on five of the most important [41].
Airway management and ventilation
Out of 10,000 episodes of anaesthesia, documented severe
aspiration occurs in 1–5 cases; aspiration might also occur
unobserved during all phases of anaesthesia, from induction to
recovery [72]. In an otherwise unstressed individual, this
unobserved aspiration (“microaspiration”) might cause no
serious complications, but because the surgical intervention
challenges the immune system, the lungs may be more
susceptible to exposure to minor amounts of bacteria from the
oral cavity. Abdominal surgery clearly carries a higher risk of
postoperative pulmonary complications than other types of
surgery do; measures to reduce the rate of these complications
will clearly influence patient outcome [73, 74].
There is an ongoing debate on the extent to which oral
hygiene measures, types of endotracheal tubing cuffs, cuff
pressure control and continuous supraglottic suctioning
might ameliorate postoperative pulmonary complications
[75]. In a study of 86 patients who underwent oesophagec-
tomy, the incidence of postoperative pneumonia was
significantly lower among patients who brushed their teeth
five times a day than among patients who used standard
oral care as usual [76]. With a large cohort of post-cardiac
surgery patients, Bouza et al. demonstrated the cost-
effectiveness of supraglottic suctioning; however, the
effectiveness of this measure as an intraoperative interven-
tion and during other types of surgery has still to be proven
[77]. In 2000, the Acute Respiratory Distress Syndrome
Clinical Network trial demonstrated for the first time a lower
mortality ina large cohortofpatientswithacute lunginjuryor
acute respiratory distress when a protective ventilatory
strategywas applied using small tidalvolumes and predefined
positive end-expiratory pressure settings [78]. Other recent
studies clearly hint that the use of protective ventilatory
settings during anaesthesia in the operating room—especially
during large abdominal surgery—reduce the inflammatory
reaction of the human body and very likely improve patient
outcome [79–81].
Induction of anaesthesia leads to atelectasis formation,
predominately in the caudal-dependent parts of the lungs.
Prevention and reversal of atelectasis increases functional
residual capacity and improves gas exchange in the
postoperative period [82, 83]. Measures to reduce atelecta-
sis might, therefore, reduce postoperative pulmonary
complications. The usefulness of positive end-expiratory
pressure intraoperatively is controversial, but Squadrone et
al. have demonstrated the positive effects of applying
continuous positive pressure in the recovery room after
major elective abdominal surgery [84, 85].
In conclusion, oral hygiene measures and, at least in
high-risk patients, the use of special endotracheal tubes
clearly influence the outcome of patients who undergo
major abdominal surgery. In addition, protective intra-
operative ventilatory settings should be used because they
influence the systemic inflammatory response to surgery
and ventilation. Finally, there is good rationale to prevent or
reverse atelectasis, but the number of studies supporting
this approach on an evidence-based level is limited.
Choice of anaesthetic agents
The fact that anaesthetic agents modulate the response of an
organism to surgical stress and hence can influence patient
outcome after major abdominal surgery represents a
double-edged sword. These drugs can either enhance or
lower the ability of the immune system to sufficiently react
to sources of infection during the postoperative period, and
they can increase or decrease mesenteric perfusion [86–88].
The effect on mesenteric blood flow does not depend on
whether balanced general anaesthesia (i.e. opioids com-
bined with volatile anaesthetic agents), pure inhaled
anaesthesia or pure intravenous anaesthesia is used, but on
the degree to which the applied technique influences
haemodynamics in general.
The combination of general anaesthesia and thoracic
epidural anaesthesia (TEA) has become the technique of
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TEA improves mesenteric blood flow, increases oxygen
supply to the abdominal cavity and allows sufficient pain
control after surgery (the latter represents one of the
cornerstones of the fast-track surgery concept) [89–91].
Very recent studies have suggested that for some types of
cancer TEA might also reduce the rate of recurrence after
surgical resection. The possibility of reducing tumour
recurrence makes the combination of general anaesthesia
and TEA even more appealing, even if some contra-
indications for its use might exist [92–95].
Glucose control
Numerous studies have demonstrated the negative effects
of intra-hospital hyperglycaemic phases on the rate of
postoperative complications (including wound healing),
nosocomial infections, length of hospital stay and
mortality [96–100]. An influential study by Van de Berghe
introduced the concept of intensive glucose control for
critical care patients, which has been promoted and
quickly applied to a more general population of intensive
care patients [101]. However, studies of this approach that
were performed with patients with septicaemia and in a
general population of intensive care patients raised serious
concerns about subsequent severe hypoglycaemia and
about the effects on outcome that were originally reported
[102, 103].
In consequence, this concept was modified toward less
extreme blood glucose levels, but glucose control per se can
still be regarded as a golden standard for reducing
perioperative complications. The optimal glucose level in
the perioperative setting has not yet been prospectively
investigated. There is some evidence that in daily practice
the blood glucose level should be kept between 110 and
180 mg/dl to simultaneously reduce the incidence of
hyperglycaemia-related complications, such as compromise
of the immune system, and to avoid hypoglycaemia [99].
Intensified glucose control requires well-trained, motivated
health care staff. Accurate measurement of the actual
glucose level at the bedside, or the actual value being
available without delay, is also necessary.
Fluid management
Traditionally large amounts of fluids, either in the form
of crystalloid solutions or as a combination of crystal-
loids and colloids, have been applied during major
abdominal surgery [41]. However, studies on the positive
effects of restrictive fluid management on postoperative
complications and the concept of fast-track surgery have
challenged this traditional approach and have opened up
discussion on how liberal or restrictive perioperative
volume therapy should be [104, 105]. Today, a more
differentiated and individualised approach is suggested.
Studies have shown that in healthy individuals, restric-
tive (versus moderately liberal) volume replacement does
not provide any beneficial effect on patient outcome. A
recent review of seven prospective studies on restrictive
(998–2,740 ml) and liberal (2,750–5,388 ml) volume
replacement demonstrated inconsistent results, and the
authors stated that “evidence-based guidelines for optimal
procedure-specific peri-operative fixed-volume regimens
cannot be formulated” [105]. However, there is evidence
that high-risk surgical patients might profit from early
intervention and goal-directed therapy in the perioperative
phase, including the optimisation of volume status, to
achieve the best rate of oxygen delivery to the cells of the
body and in particular to cells involved in the mechanical
and biological stress caused by the surgical intervention
[106–108]. Because the rate of oxygen delivery is deter-
mined by cardiac output, volume status, contractility,
peripheral resistance and oxygen content, it becomes
evident that its optimisation requires extended monitoring
and a multi-factorial approach.
In the monitoring of patients who receive volume therapy,
there has been a clear paradigmatic shift from pressure- to
volume-targetedparametersandtheuseofmonitoringdevices
that are less invasive than the traditional pulmonary artery
catheter. Early intervention might even include preoperative
transfer to an intensive care unit (ICU) and transport of an
already “optimised” patient to the operating room [109–111].
There is also ongoing debate on the best solution to use for
volume replacement and volume optimisation. Studies of the
use of colloidal volume replacement solutions such as
hydroxyethylstarch and gelatin in intensive care medicine
demonstratedthattheymaynegativelyaffectpatient outcome,
especially renal function [102, 112–114]. However, those
studies were performed in the intensive care setting, mostly
with patients who had septicaemia and extended use of these
substances. Even so, colloidal volume replacement acts faster
than cristalloids in restoring plasma volume, a characteristic
that is particularly important if a large volume is lost during
the course of surgery [115]. The use of colloidal volume
replacement may be contraindicated for patients with pre-
existing kidney problems: one study clearly demonstrated
that the risk of a negative impact on kidney function
increases with the preoperative renal Sequential Organ
Failure Assessment score and, therefore, with the pre-
existing degree of renal impairment.
In summary, a moderately restrictive volume replace-
ment strategy for uncompromised patients seems adequate;
extreme volume loading definitely should be avoided.
High-risk surgical patients should be identified early,
monitored for plasma volume and ideally already be
optimised with regard to oxygen delivery when they arrive
Langenbecks Arch Surg (2011) 396:591–606 599at the operating room. Colloids should be made available
for volume replacement during surgery because they act
faster than cristalloids in restoring plasma volume and thus
in ensuring oxygen supply. The amount given should not
exceed 20 ml/kg body weight and day. In cases of pre-
existing renal impairment, the use of artificial colloids
should be used more cautiously.
Temperature management
Numerous prospective randomised studies have demon-
strated the negative effects of perioperative hypothermia on
the duration of muscle relaxants, intraoperative blood loss,
transfusion requirements, shivering, discomfort, postanaes-
thetic recovery, morbid cardiac events, surgical wound
infections and duration of hospitalisation. Adequate control
of body temperature, with warm forced-air blankets or
warm fluids, is thus critical for patient outcome [116].
The efficacy of a forced-air warming system is deter-
mined mainly by the design of the blanket. During
abdominal surgery, small blankets (i.e. upper body blankets
and paediatric blankets) are usually used, which reduces the
requirement on the airflow from the power unit. Neverthe-
less, the largest blanket that is feasible should be used.
Forced-air warming blankets alone might not be sufficient
to keep a patient normothermic throughout surgery, in cases
in which large amounts of fluids are infused during the
procedure, fluid warming should be employed as well.
Another approach is to pre-warm the patient. In a
recently published pilot study, warming of patients before
they reach the operating room reduced the postoperative
degree of hypothermia, as pre-warming effectively reduces
the redistribution of heat after induction of anaesthesia
[117]. Effective pre-warming requires 30–60 min in a
holding area and also the willingness of the care team to
master the organizational challenges of this approach.
Intensive and intermediate postoperative care
The concept of fast-track surgery has also challenged the
traditional use of ICU resources for patients who undergo
major gastrointestinal surgery and are at low or moderate risk
of a poor outcome. There is no rationale for transferring an
extubated, stable, normothermic patient from the operating
room to an ICU, and evidence is growing that transfer to a
normal surgical ward might be preferred. However, this
decision requires close interdisciplinary cooperation and
well-defined protocols regarding how the postoperative care
of the patient will be carried out. This cooperation increases
the workload for the general ward and requires highly
motivatedwell-trainednursing staff to beeffective [118, 119].
The establishment of intermediate care wards that can
delivera higherlevel ofcare(staff andmonitoringequipment)
might further reduce the need for intensive care beds for high-
risk patients who have undergone elective abdominal surgery.
For patients who undergo major vascular surgery and thoracic
surgery, the adequacy of an intermediate care unit has been
demonstrated [120, 121]. Nursing, monitoring and treatment
options may vary, but whatever the infrastructure of the
intermediate care unit might be, it generally provides basic
haemodynamic monitoring, the ability to provide one or two
intravenous drugs continuously and the ability to perform
non-invasive ventilation.
Patients undergoing major abdominal surgery who are at
high risk of a poor outcome—particularly elderly patients
and patients with underlying chronic respiratory diseases—
should be scheduled for intensive care treatment [122–124].
In addition, should extended monitoring, invasive mechan-
ical ventilation, continuous application of several intrave-
nous drugs or any kind of extracorporeal procedure be
required, the patient must be transferred to a high-
dependency ICU. For these patients, even preoperative
admission to an ICU and the optimisation of their
preoperative status might facilitate their journey through
major abdominal surgery and improve the outcome.
In summary, most patients who undergo elective major
abdominal surgery do not necessarily require intensive care
resources, whereas high-risk patients might even profit
from preoperative care in an ICU. Ideally, a step-up–step-
down ICU can be realized that would allow the level of care
to be adapted to the needs of the patient without physically
changing the location of the patient [125].
Postoperative management
The care strategy for patients after surgery has shifted
tremendously over time and has been influenced primarily by
modern fast-track programmes (please see the accompanying
article on “fast track perioperative management: physiologic
principles”). Currently, there are six major elements to the
postoperative recovery period (Fig. 1). All of these principles
are interrelated and affect the use and effectiveness of each
other. Importantly, their effectiveness also depends greatly on
the availability and sufficiency of qualified nurses and
physiotherapists. This dependency often represents a key
bottleneck in postsurgical treatment, particularly in times of
increasing economic demands. And again, close cooperation
between the surgeon and anaesthesiologist is critical to the
implementation of these elements.
Modern opioid-sparing analgesia
A critical factor in postoperative management is addressing
continuous pain, which decreases the patient’s interest in
and ability for mobilisation, interferes with the performance
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principles of nonopioid- or opioid-sparing analgesia as well
as regional anaesthetic techniques have been shown to
reduce the rate of postoperative paralytic ileus and to
accelerate postoperative recovery [126–128]. Because
modern pain management is becoming increasingly com-
plicated, more and more hospitals are implementing
specialized teams (“acute pain service”) that supervise
postoperative pain medication. Whether continuous admin-
istration of local anaesthetics into the surgical site offers
clinical benefit remains to be demonstrated [129].
Early mobilisation and prevention of venous
thromboembolism
Early mobilization is critical for postoperative recovery and
the prevention of postoperative complications, particularly
pulmonary complications and venous thromboembolism
(VTE). Numerous risk factors for VTE have been identi-
fied, including the presence of cancer, which increases the
risk several-fold [130–133]. The risk for VTE is particu-
larly high in the first few months after diagnosis and in the
presence of distant metastases, and it is further increased by
chemotherapy and surgery [130, 133]. While it is beyond
the scope of this review to comprehensively cover this
topic, practical recommendations on the prophylaxis of
VTE, adjusted according to recent guidelines [131–135],
are listed in Table 5.
Extended lung expansion exercises
Extended lung expansion exercise is the first and most
important strategy for reducing postoperative pulmonary
complications [19, 20, 136]. It is also recommended that
patients with restricted pulmonary function perform these
exercises before surgery. Furthermore, for patients who are
at high risk of developing a pulmonary complication (see
“Pulmonary risk evaluation” above), the selective but non-
routine use of nasogastric tubes is recommended [19].
Early removal of tubes, catheters and drains
Until recently, prophylactic nasogastric decompression tubes
were routinely used for prolonged postoperative time periods
with the intent of reducing nausea and vomiting, decreasing
abdominal distension and lowering the risk of pulmonary
aspiration. This clinicalpractice, however, is not supported by
the literature [137–139]. At our University Medical Center, a
nasogastric tube is only recommended as long as the
retrograde fluid delivery of the tube exceeds 100 ml/day.
The persistence of other catheters and drains is similarly
problematic. Most importantly, they restrict the patient’s
freedom and, in most cases, limit the patient’sd e m a n df o r
mobilisation. The placement of drains in particular is a highly
debated issue [140]. The rationale of placing an intra-
abdominal drain after gastrointestinal surgery is to screen
for postoperative haemorrhage, to identify an early enteric,
bile, pancreatic or chyle leak and to allow early intervention
(e.g. transfusion, interventional treatment or reoperation). In
cases in which the drain adequately “controls” the leak,
reoperation or intervention may even be avoided [141, 142].
Although a growing body of evidence suggests that
nonemergency gastrointestinal surgery can be performed
safely without prophylactic intra-abdominal drainage and
that drainage may even be harmful after hepatic resection in
chronic liver disease and after appendectomy, it remains
highly controversial whether drainage is desirable [143,
144]. It also remains unclear, particularly for pancreatic
resections, whether short-term drainage is superior to long-
term drainage [144]. At our University Medical Center, we
routinely place abdominal drains after major gastrointestinal
surgery, primarily in order to detect complications as early as
possible and to reduce the rate of relaparotomy in cases of
anastomotic leak.
Table 5 Practical guidelines on the prophylaxis of venous thrombo-
embolism
In the absence of acute bleeding or other contraindications, all patients
hospitalised with an acute medical illness should receive VTE
prophylaxis that is commenced preoperatively.
In patients who are undergoing low-risk surgery and have no risk
factors for VTE, pharmacologic prophylaxis is generally not
recommended, only graduated compression stockings and frequent
ambulation. In our university hospital, however, we prefer to use
VTE prophylaxis for every hospitalised patient (in the absence of
acute bleeding or other contraindications).
Common VTE prophylaxis options include low-dose unfractionated
heparin (UFH) and low-molecular-weight heparin (LMWH). The
latter is contraindicated in patients with renal insufficiency.
Patients at high risk for developing VTE should receive higher doses
of either UFH or LMWH than moderate- or low-risk patients (e.g.
enoxaparin 40 versus 20 mg daily). Patients with chronic atrial
fibrillation or a mechanical heart valve or who otherwise require
therapeutic anticoagulation need to receive weight-adapted LMWH,
twice daily, or intravenous aPTT-adjusted UFH.
Because nonemergency surgery is usually scheduled during daytime
hours, subcutaneous prophylaxis should be given in the evening. For
patients who require therapeutic anticoagulation, LMWH should be
paused on the morning of the operation, while UFH infusion should
be discontinued 4 h preoperatively.
In patients at low or medium risk for postoperative bleeding, LMWH
should be continued on the evening after surgery and last until
discharge from hospital. In patients who are at high risk for
postoperative bleeding, intravenous UFH should be continued
immediately after transfer to the ICU (commonly 100–200 U/h).
Patients who had undergone major abdominal or pelvic surgery for
gastrointestinal malignancy should be considered for postdischarge
VTE prophylaxis for up to 4 weeks after surgery in the following
situations: residual or metastatic disease, obesity or previous history
of VTE.
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Early oral nutrition is recommended for non-emergency
gastrointestinal surgery. An earlier practice had been
temporary starvation; the rationale was to prevent postop-
erative nausea and to protect the surgical intestinal
anastomosis from mechanical stress. However, several
clinical trials failed to demonstrate a clear benefit for this
practice (summarized in [145]), and early nutrition is now
standard practice. Because postoperative nausea will pre-
vent oral nutrition and hence limit early recovery and
encourage postoperative ileus, nausea and vomiting should
be treated with serotonin antagonists, low-dose dexameth-
asone, droperidol or dimenhydrinate [146].
Early detection of complications
The final important aspect of postoperative care is the early
detection of complications. Elderly patients in particular are
at increased risk for developing complications, mainly due
to their reduced physiologic reserves, multiple (age-related)
comorbidities, polypharmacy and a frequently altered
response to commonly used drugs (altered pharmacody-
namics and pharmacokinetics). Because only a small group
of patients accounts for the majority of postoperative
morbidity and mortality after gastrointestinal surgery, it is
crucial that these high-risk patients be identified (see
section “Preoperative risk assessment” above). In addition,
for these patients, extra efforts must be made to prevent
potential complications and to identify actual complications
as early as possible [147, 148].
For elderly patients, a complication termed postoperative
cognitive decline (POCD) appears to be an increasing
problem. In contrast to postoperative delirium, which is
defined as confusion and altered consciousness that lasts for
days, POCD primarily effects memory and executive
function and may last for weeks or months [149]. It is
unclear how this complication can be prevented, if at all.
Conclusion
Standard perioperative management in elective gastrointes-
tinal surgery has advanced significantly in the last decade.
As a truly multidisciplinary approach, it involves close
interaction between the disciplines of surgery, anaesthesi-
ology and intensive care medicine throughout the preoper-
ative, intraoperative and postoperative phases. Major
improvements have been based on evidence (see Fig. 1),
and their implementation into routine clinical practice
has enabled increasingly complex surgical procedures for
an ageing patient population with significant comorbid-
ities. For these reasons, major gastrointestinal surgery
can now be safely performed with acceptable morbidity
and mortality rates.
Conflicts of interest None for MG and BMG; MQ is a member of
the international advisory board of COVIDIEN.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Ghaferi AA, Birkmeyer JD, Dimick JB (2009) Variation in
hospital mortality associated with inpatient surgery. N Engl J
Med 361(14):1368–1375
2. Jencks SF, Williams MV, Coleman EA (2009) Rehospitalizations
among patients in the Medicare fee-for-service program. N Engl
J Med 360(14):1418–1428
3. Deutsche Gesellschaft für Anästhesiologie und Intensivmedi-
zin DGfIM, Deutsche Gesellschaft für Chirurgie (2010)
Preoperative evaluation of adult patients prior to elective,
non-cardiac surgery: joint recommendations of German
Society of Anesthesiology and Intensive Care Medicine,
German Society of Surgery and German Society of Internal
Medicine. Anaesthesist 59(11):1041–1050
4. Ryding AD, Kumar S, Worthington AM, Burgess D (2009)
Prognostic value of brain natriuretic peptide in noncardiac
surgery: a meta-analysis. Anesthesiology 111(2):311–319
5. Cuthbertson BH, Amiri AR, Croal BL, Rajagopalan S, Alozairi O,
BrittendenJ,HillisGS(2007)UtilityofB-typenatriureticpeptidein
predictingperioperativecardiaceventsinpatientsundergoingmajor
non-cardiac surgery. Br J Anaesth 99(2):170–176
6. Feringa HH, Schouten O, Dunkelgrun M, Bax JJ, Boersma E,
Elhendy A, de Jonge R, Karagiannis SE, Vidakovic R, Polder-
mans D (2007) Plasma N-terminal pro-B-type natriuretic peptide
as long-term prognostic marker after major vascular surgery.
Heart 93(2):226–231
7. Ackland GL, Edwards M (2010) Defining higher-risk surgery.
Curr Opin Crit Care 16(4):339–346
8. Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA,
Kumbhani DJ (2005) Determinants of long-term survival after
major surgery and the adverse effect of postoperative complica-
tions. Ann Surg 242(3):326–341, discussion 341–323
9. Copeland GP, Jones D, Walters M (1991) POSSUM: a scoring
system for surgical audit. Br J Surg 78(3):355–360
10. Haga Y, Ikei S, Ogawa M (1999) Estimation of Physiologic
Ability and Surgical Stress (E-PASS) as a new prediction scoring
system for postoperative morbidity and mortality following
elective gastrointestinal surgery. Surg Today 29(3):219–225
11. Markus PM, Martell J, Leister I, Horstmann O, Brinker J, Becker
H (2005) Predicting postoperative morbidity by clinical assess-
ment. Br J Surg 92(1):101–106
12. Cohen ME, Dimick JB, Bilimoria KY, Ko CY, Richards K, Hall
BL (2009) Risk adjustment in the American College of Surgeons
National Surgical Quality Improvement Program: a comparison
of logistic versus hierarchical modeling. J Am Coll Surg 209
(6):687–693
13. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E,
Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK,
Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams
602 Langenbecks Arch Surg (2011) 396:591–606CD, Anderson JL, Antman EM, Buller CE, Creager MA,
Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF,
Hunt SA, Lytle BW, Md RN, Ornato JP, Page RL, Riegel B,
Tarkington LG, Yancy CW (2007) ACC/AHA 2007 Guide-
lines on Perioperative Cardiovascular Evaluation and Care for
Noncardiac Surgery: Executive Summary: A Report of the
American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Writing Committee to
Revise the 2002 Guidelines on Perioperative Cardiovascular
Evaluation for Noncardiac Surgery): Developed in Collaboration
With the American Society of Echocardiography, American
Society of Nuclear Cardiology, Heart Rhythm Society, Society
of Cardiovascular Anesthesiologists, Society for Cardiovascu-
lar Angiography and Interventions, Society for Vascular
Medicine and Biology, and Society for Vascular Surgery.
Circulation 116(17):1971–1996
14. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E,
Fowkes G, Gorenek B, Hennerici MG, Lung B, Kelm M,
Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe
F, Pierard L, Ponikowski P, Schmid JP, Sellevold OF, Sicari R,
Van den Berghe G, Vermassen F, Hoeks SE, Vanhorebeek I
(2009) Guidelines for pre-operative cardiac risk assessment and
perioperative cardiac management in non-cardiac surgery: the
Task Force for Preoperative Cardiac Risk Assessment and
Perioperative Cardiac Management in Non-cardiac Surgery of
the European Society of Cardiology (ESC) and European Society
of Anaesthesiology (ESA). Eur Heart J 30(22):2769–2812
15. Williams FM, Bergin JD (2009) Cardiac screening before
noncardiac surgery. Surg Clin North Am 89(4):747–762, vii
16. Froehlich JB, Fleisher LA (2009) Noncardiac surgery in the
patient with heart disease. Anesthesiol Clin 27(4):649–671
17. Hammill BG, Curtis LH, Bennett-Guerrero E, O'Connor CM,
Jollis JG, Schulman KA, Hernandez AF (2008) Impact of heart
failure on patients undergoing major noncardiac surgery. Anes-
thesiology 108(4):559–567
18. Smetana GW, Lawrence VA, Cornell JE (2006) Preoperative
pulmonary risk stratification for noncardiothoracic surgery:
systematic review for the American College of Physicians. Ann
Intern Med 144(8):581–595
19. Qaseem A, Snow V, Fitterman N, Hornbake ER, Lawrence VA,
Smetana GW, Weiss K, Owens DK, Aronson M, Barry P, Casey
DE Jr, Cross JT Jr, Fitterman N, Sherif KD, Weiss KB (2006)
Risk assessment for and strategies to reduce perioperative
pulmonary complications for patients undergoing noncardio-
thoracic surgery: a guideline from the American College of
Physicians. Ann Intern Med 144(8):575–580
20. Cook MW, Lisco SJ (2009) Prevention of postoperative
pulmonary complications. Int Anesthesiol Clin 47(4):65–88
21. Fleischmann KE, Beckman JA, Buller CE, Calkins H,
Fleisher LA, Freeman WK, Froehlich JB, Kasper EK, Kersten
JR, Robb JF, Valentine RJ (2009) 2009 ACCF/AHA focused
update on perioperative beta blockade. J Am Coll Cardiol 54
(22):2102–2128
22. Duncan AI, Koch CG, Xu M, Manlapaz M, Batdorf B, Pitas G,
Starr N (2007) Recent metformin ingestion does not increase in-
hospital morbidity or mortality after cardiac surgery. Anesth
Analg 104(1):42–50
23. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB,
Moliterno DJ, O'Gara P, Whitlow P (2007) Prevention of
premature discontinuation of dual anti-platelet therapy in patients
with coronary artery stents: a science advisory from the
American Heart Association, American College of Cardiology,
Society for Cardiovascular Angiography and Interventions,
American College of Surgeons, and American Dental Associa-
tion, with representation from the American College of Physi-
cians. Circulation 115(6):813–818
24. Jambor C, Spannagl M, Zwissler B (2009) Perioperative
management of patients with coronary stents in non-cardiac
surgery. Anaesthesist 58(10):971–985
25. Popescu WM (2010) Perioperative management of the patient
with a coronary stent. Curr Opin Anaesthesiol 23(1):109–115
26. Brennan KA, Genever RW (2010) Managing Parkinson's disease
during surgery. BMJ 341:c5718
27. Stevenson WG, Chaitman BR, Ellenbogen KA, Epstein AE,
Gross WL, Hayes DL, Strickberger SA, Sweeney MO (2004)
Clinical assessment and management of patients with implanted
cardioverter-defibrillators presenting to nonelectrophysiologists.
Circulation 110(25):3866–3869
28. American Society of Anesthesiologists Task Force on Perioper-
ative Management of Patients with Cardiac Rhythm Manage-
ment Devices (2005) Practice advisory for the perioperative
management of patients with cardiac rhythm management
devices: pacemakers and implantable cardioverter-defibrillators.
Anesthesiology 103(1):186–198
29. Rozner MA (2007) The patient with a cardiac pacemaker or
implanted defibrillator and management during anaesthesia. Curr
Opin Anaesthesiol 20(3):261–268
30. Kehlet H (1997) Multimodal approach to control postoperative
pathophysiology and rehabilitation. Br J Anaesth 78(5):606–617
31. Kehlet H, Dahl JB (2003) Anaesthesia, surgery, and challenges
in postoperative recovery. Lancet 362(9399):1921–1928
32. Kehlet H, Wilmore DW (2008) Evidence-based surgical care and
the evolution of fast-track surgery. Ann Surg 248(2):189–198
33. Kehlet H (2008) Fast-track colorectal surgery. Lancet 371
(9615):791–793
34. Burke P, Mealy K, Gillen P, Joyce W, Traynor O, Hyland J
(1994) Requirement for bowel preparation in colorectal surgery.
Br J Surg 81(6):907–910
35. Santos JC Jr, Batista J, Sirimarco MT, Guimaraes AS, Levy CE
(1994) Prospective randomized trial of mechanical bowel
preparation in patients undergoing elective colorectal surgery.
Br J Surg 81(11):1673–1676
36. Miettinen RP, Laitinen ST, Makela JT, Paakkonen ME (2000)
Bowel preparation with oral polyethylene glycol electrolyte
solution vs. no preparation in elective open colorectal surgery:
prospective, randomized study. Dis Colon Rectum 43(5):669–
675, discussion 675–667
37. Zmora O, Mahajna A, Bar-Zakai B, Rosin D, Hershko D,
Shabtai M, Krausz MM, Ayalon A (2003) Colon and rectal
surgery without mechanical bowel preparation: a randomized
prospective trial. Ann Surg 237(3):363–367
38. Pena-Soria MJ, Mayol JM, Anula R, Arbeo-Escolar A,
Fernandez-Represa JA (2008) Single-blinded randomized trial
of mechanical bowel preparation for colon surgery with primary
intraperitoneal anastomosis. J Gastrointest Surg 12(12):2103–
2108, discussion 2108–2109
39. Pineda CE, Shelton AA, Hernandez-Boussard T, Morton JM,
Welton ML (2008) Mechanical bowel preparation in intestinal
surgery: a meta-analysis and review of the literature. J Gastro-
intest Surg 12(11):2037–2044
40. Bretagnol F, Panis Y, Rullier E, Rouanet P, Berdah S, Dousset B,
Portier G, Benoist S, Chipponi J, Vicaut E (2010) Rectal cancer
surgery with or without bowel preparation: the French GREC-
CAR III multicenter single-blinded randomized trial. Ann Surg
252(5):863–868
41. Banz VM, Jakob SM, Inderbitzin D (2010) Improving outcome
after major surgery: pathophysiological considerations. Anesth
Analg, 2010 Aug 24
42. Lindstrom D, Sadr Azodi O, Wladis A, Tonnesen H, Linder S,
Nasell H, Ponzer S, Adami J (2008) Effects of a perioperative
smoking cessation intervention on postoperative complications: a
randomized trial. Ann Surg 248(5):739–745
Langenbecks Arch Surg (2011) 396:591–606 60343. Thomsen T, Tonnesen H, Moller AM (2009) Effect of
preoperative smoking cessation interventions on postoperative
complications and smoking cessation. Br J Surg 96(5):451–461
44. Windsor A, Braga M, Martindale R, Buenos R, Tepaske R,
Kraehenbuehl L, Weimann A (2004) Fit for surgery: an expert
panel review on optimising patients prior to surgery, with a
particular focus on nutrition. Surgeon 2(6):315–319
45. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF (1999)
Preoperative serum albumin level as a predictor of operative
mortality and morbidity: results from the National VA Surgical
Risk Study. Arch Surg 134(1):36–42
46. Bozzetti F, Gavazzi C, Miceli R, Rossi N, Mariani L, Cozzaglio
L, Bonfanti G, Piacenza S (2000) Perioperative total parenteral
nutrition in malnourished, gastrointestinal cancer patients: a
randomized, clinical trial. JPEN J Parenter Enteral Nutr 24(1):7–
14
47. Bozzetti F, Gianotti L, Braga M, Di Carlo V, Mariani L (2007)
Postoperative complications in gastrointestinal cancer patients:
the joint role of the nutritional status and the nutritional support.
Clin Nutr 26(6):698–709
48. Koretz RL, Lipman TO, Klein S (2001) AGA technical review
on parenteral nutrition. Gastroenterology 121(4):970–1001
49. Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ (2009)
Effect of body mass index on short-term outcomes after
colectomy for cancer. J Am Coll Surg 208(1):53–61
50. Tokunaga M, Hiki N, Fukunaga T, Ogura T, Miyata S,
Yamaguchi T (2009) Effect of individual fat areas on early
surgical outcomes after open gastrectomy for gastric cancer. Br J
Surg 96(5):496–500
51. Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W,
Pories W, Courcoulas A, McCloskey C, Mitchell J, Patterson E,
Pomp A, Staten MA, Yanovski SZ, Thirlby R, Wolfe B (2009)
Perioperative safety in the longitudinal assessment of bariatric
surgery. N Engl J Med 361(5):445–454
52. Sahai SK, Zalpour A, Rozner MA (2010) Preoperative evalua-
tion of the oncology patient. Med Clin North Am 94(2):403–419
53. Youssef G, Links M (2005) The prevention and management of
cardiovascular complications of chemotherapy in patients with
cancer. Am J Cardiovasc Drugs 5(4):233–243
54. Werner-Wasik M, Yorke E, Deasy J, Nam J, Marks LB (2010)
Radiation dose-volume effects in the esophagus. Int J Radiat
Oncol Biol Phys 76(3 Suppl):S86–S93
55. Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten
Haken RK, Miften M (2010) Radiation dose-volume effects in
the stomach and small bowel. Int J Radiat Oncol Biol Phys 76(3
Suppl):S101–S107
56. Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH,
Dellinger EP, Herbosa T, Joseph S, Kibatala PL, Lapitan MC,
Merry AF, Moorthy K, Reznick RK, Taylor B, Gawande AA
(2009) A surgical safety checklist to reduce morbidity and
mortality in a global population. N Engl J Med 360(5):491–499
57. de Vries EN, Prins HA, Crolla RM, den Outer AJ, van Andel G,
van Helden SH, Schlack WS, van Putten MA, Gouma DJ,
Dijkgraaf MG, Smorenburg SM, Boermeester MA (2010) Effect
of a comprehensive surgical safety system on patient outcomes.
N Engl J Med 363(20):1928–1937
58. Stone HH, Hooper CA, Kolb LD, Geheber CE, Dawkins EJ
(1976) Antibiotic prophylaxis in gastric, biliary and colonic
surgery. Ann Surg 184(4):443–452
59. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL,
Burke JP (1992) The timing of prophylactic administration of
antibiotics and the risk of surgical-wound infection. N Engl J
Med 326(5):281–286
60. Bratzler DW, Houck PM (2005) Antimicrobial prophylaxis for
surgery: an advisory statement from the National Surgical
Infection Prevention Project. Am J Surg 189(4):395–404
61. Edmiston CE, Krepel C, Kelly H, Larson J, Andris D, Hennen C,
Nakeeb A, Wallace JR (2004) Perioperative antibiotic prophy-
laxis in the gastric bypass patient: do we achieve therapeutic
levels? Surgery 136(4):738–747
62. Uckay I, Harbarth S, Peter R, Lew D, Hoffmeyer P, Pittet D
(2010) Preventing surgical site infections. Expert Rev Anti Infect
Ther 8(6):657–670
63. Manian FA, Meyer PL, Setzer J, Senkel D (2003) Surgical site
infections associated with methicillin-resistant Staphylococcus
aureus: do postoperative factors play a role? Clin Infect Dis 36
(7):863–868
64. Crabtree TD, Pelletier SJ, Gleason TG, Pruett TL, Sawyer RG
(1999) Clinical characteristics and antibiotic utilization in
surgical patients with Clostridium difficile-associated diarrhea.
Am Surg 65(6):507–511, discussion 511–502
65. Carignan A, Allard C, Pepin J, Cossette B, Nault V, Valiquette L
(2008) Risk of Clostridium difficile infection after perioperative
antibacterial prophylaxis before and during an outbreak of
infection due to a hypervirulent strain. Clin Infect Dis 46
(12):1838–1843
66. Butterly A, Schmidt U, Wiener-Kronish J (2010) Methicillin-
resistant Staphylococcus aureus colonization, its relationship to
nosocomial infection, and efficacy of control methods. Anesthe-
siology 113(6):1453–1459
67. Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z,
Kertzman V, Cohen O, Milo S (2002) Vancomycin versus
cefazolin prophylaxis for cardiac surgery in the setting of a high
prevalence of methicillin-resistant staphylococcal infections. J
Thorac Cardiovasc Surg 123(2):326–332
68. Tacconelli E, Cataldo MA, Albanese A, Tumbarello M, Arduini
E, Spanu T, Fadda G, Anile C, Maira G, Federico G, Cauda R
(2008) Vancomycin versus cefazolin prophylaxis for cerebrospi-
nal shunt placement in a hospital with a high prevalence of
meticillin-resistant Staphylococcus aureus. J Hosp Infect 69
(4):337–344
69. Diana M, Hübner M, Eisenring M, Zanetti G, Troillet N,
Demartines N (2011) Measures to prevent surgical site
infections: what surgeons (should) do. World J Surg 35
(2):280–288
70. Klein J (2008) Multimodal multidisciplinary standardization of
perioperative care: still a long way to go. Curr Opin Anaesthesiol
21(2):187–190
71. Burkitt KH, Mor MK, Jain R, Kruszewski MS, McCray EE,
Moreland ME, Muder RR, Obrosky DS, Sevick MA, Wilson
MA, Fine MJ (2009) Toyota production system quality improve-
ment initiative improves perioperative antibiotic therapy. Am J
Manag Care 15(9):633–642
72. Benington S, Severn A (2007) Preventing aspiration and
regurgitation. Anaesthesia Intensive Care Med 8:368–372
73. Smetana GW, Cohn SL, Lawrence VA (2004) Update in
perioperative medicine. Ann Intern Med 140(6):452–461
74. Cohn SL, Smetana GW (2007) Update in perioperative medi-
cine. Ann Intern Med 147(4):263–270
75. Warner DO (2000) Preventing postoperative pulmonary compli-
cations: the role of the anesthesiologist. Anesthesiology 92
(5):1467–1472
76. Akutsu Y, Matsubara H, Shuto K, Shiratori T, Uesato M,
Miyazawa Y, Hoshino I, Murakami K, Usui A, Kano M,
Miyauchi H (2010) Pre-operative dental brushing can reduce
the risk of postoperative pneumonia in esophageal cancer
patients. Surgery 147(4):497–502
77. Bouza E, Perez MJ, Munoz P, Rincon C, Barrio JM, Hortal J
(2008) Continuous aspiration of subglottic secretions in the
prevention of ventilator-associated pneumonia in the post-
operative period of major heart surgery. Chest 134(5):938–
946
604 Langenbecks Arch Surg (2011) 396:591–60678. The Acute Respiratory Distress Syndrome Network (2000)
Ventilation with lower tidal volumes as compared with tradition-
al tidal volumes for acute lung injury and the acute respiratory
distress syndrome. The Acute Respiratory Distress Syndrome
Network. N Engl J Med 342(18):1301–1308
79. Michelet P, D'Journo XB, Roch A, Doddoli C, Marin V,
Papazian L, Decamps I, Bregeon F, Thomas P, Auffray JP
(2006) Protective ventilation influences systemic inflammation
after esophagectomy: a randomized controlled study. Anesthesi-
ology 105(5):911–919
80. Fernandez-Perez ER, Sprung J, Afessa B, Warner DO, Vachon
CM, Schroeder DR, Brown DR, Hubmayr RD, Gajic O (2009)
Intraoperative ventilator settings and acute lung injury after
elective surgery: a nested case control study. Thorax 64(2):121–
127
81. Hans GA, Sottiaux TM, Lamy ML, Joris JL (2009) Ventilatory
management during routine general anaesthesia. Eur J Anaes-
thesiol 26(1):1–8
82. Magnusson L, Spahn DR (2003) New concepts of atelectasis
during general anaesthesia. Br J Anaesth 91(1):61–72
83. Duggan M, Kavanagh BP (2005) Pulmonary atelectasis: a
pathogenic perioperative entity. Anesthesiology 102(4):838–
854
84. Imberger G, McIlroy D, Pace NL, Wetterslev J, Brok J, Moller
AM (2010) Positive end-expiratory pressure (PEEP) during
anaesthesia for the prevention of mortality and postoperative
pulmonary complications. Cochrane Database Syst Rev 9:
CD007922
85. Squadrone V, Coha M, Cerutti E, Schellino MM, Biolino P,
Occella P, Belloni G, Vilianis G, Fiore G, Cavallo F, Ranieri VM
(2005) Continuous positive airway pressure for treatment of
postoperative hypoxemia: a randomized controlled trial. JAMA
293(5):589–595
86. Kurosawa S, Kato M (2008) Anesthetics, immune cells, and
immune responses. J Anesth 22(3):263–277
87. Schneemilch CE, Schilling T, Bank U (2004) Effects of general
anaesthesia on inflammation. Best Pract Res Clin Anaesthesiol
18(3):493–507
88. Ahlers O, Nachtigall I, Lenze J, Goldmann A, Schulte E, Hohne C,
Fritz G, Keh D (2008) Intraoperative thoracic epidural anaesthesia
attenuates stress-induced immunosuppression in patients undergo-
ing major abdominal surgery. Br J Anaesth 101(6):781–787
89. Kabon B, Fleischmann E, Treschan T, Taguchi A, Kapral S,
Kurz A (2003) Thoracic epidural anesthesia increases tissue
oxygenation during major abdominal surgery. Anesth Analg 97
(6):1812–1817
90. Moraca RJ, Sheldon DG, Thirlby RC (2003) The role of epidural
anesthesia and analgesia in surgical practice. Ann Surg 238
(5):663–673
91. Fotiadis RJ, Badvie S, Weston MD, Allen-Mersh TG (2004)
Epidural analgesia in gastrointestinal surgery. Br J Surg 91
(7):828–841
92. Wuethrich PY, Hsu Schmitz SF, Kessler TM, Thalmann GN,
Studer UE, Stueber F, Burkhard FC (2010) Potential influence of
the anesthetic technique used during open radical prostatectomy
on prostate cancer-related outcome: a retrospective study.
Anesthesiology 113(3):570–576
93. Snyder GL, Greenberg S (2010) Effect of anaesthetic technique
and other perioperative factors on cancer recurrence. Br J
Anaesth 105(2):106–115
94. Gottschalk A, Ford JG, Regelin CC, You J, Mascha EJ, Sessler
DI, Durieux ME, Nemergut EC (2010) Association between
epidural analgesia and cancer recurrence after colorectal cancer
surgery. Anesthesiology 113(1):27–34
95. Tsui BC, Rashiq S, Schopflocher D, Murtha A, Broemling S,
Pillay J, Finucane BT (2010) Epidural anesthesia and cancer
recurrence rates after radical prostatectomy. Can J Anaesth 57
(2):107–112
96. Cheadle WG (2006) Risk factors for surgical site infection. Surg
Infect (Larchmt) 7(Suppl 1):S7–S11
97. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS
(2001) The association of diabetes and glucose control with
surgical-site infections among cardiothoracic surgery patients.
Infect Control Hosp Epidemiol 22(10):607–612
98. Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress
hyperglycaemia and increased risk of death after myocardial
infarction in patients with and without diabetes: a systematic
overview. Lancet 355(9206):773–778
99. Mauermann WJ, Nemergut EC (2006) The anesthesiologist's role
in the prevention of surgical site infections. Anesthesiology 105
(2):413–421
100. Ganai S, Lee KF, Merrill A, Lee MH, Bellantonio S, Brennan M,
Lindenauer P (2007) Adverse outcomes of geriatric patients
undergoing abdominal surgery who are at high risk for delirium.
Arch Surg 142(11):1072–1078
101. van den Berghe G, Wouters P, Weekers F, Verwaest C,
Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers
P, Bouillon R (2001) Intensive insulin therapy in the critically ill
patients. N Engl J Med 345(19):1359–1367
102. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller
M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S,
Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer
M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C,
Loeffler M, Reinhart K (2008) Intensive insulin therapy and
pentastarch resuscitation in severe sepsis. N Engl J Med 358
(2):125–139
103. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V,
Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC,
Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I,
Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ (2009)
Intensive versus conventional glucose control in critically ill
patients. N Engl J Med 360(13):1283–1297
104. Kehlet H (2009) Principles of fast track surgery. Multimodal
perioperative therapy programme. Chirurg 80(8):687–689
105. Bundgaard-Nielsen M, Secher NH, Kehlet H (2009) 'Liberal' vs.
'restrictive' perioperative fluid therapy–a critical assessment of
the evidence. Acta Anaesthesiol Scand 53(7):843–851
106. Holte K, Foss NB, Andersen J, Valentiner L, Lund C, Bie P,
Kehlet H (2007) Liberal or restrictive fluid administration in fast-
track colonic surgery: a randomized, double-blind study. Br J
Anaesth 99(4):500–508
107. Futier E, Constantin JM, Petit A, Chanques G, Kwiatkowski F,
Flamein R, Slim K, Sapin V, Jaber S, Bazin JE (2010)
Conservative vs restrictive individualized goal-directed fluid
replacement strategy in major abdominal surgery: a prospective
randomized trial. Arch Surg 145(12):1193–1200
108. Donati A, Loggi S, Preiser JC, Orsetti G, Munch C, Gabbanelli
V, Pelaia P, Pietropaoli P (2007) Goal-directed intraoperative
therapy reduces morbidity and length of hospital stay in high-risk
surgical patients. Chest 132(6):1817–1824
109. Forget P, Lois F, de Kock M (2010) Goal-directed fluid
management based on the pulse oximeter-derived pleth variabil-
ity index reduces lactate levels and improves fluid management.
Anesth Analg 111(4):910–914
110. Benes J, Chytra I, Altmann P, Hluchy M, Kasal E, Svitak R,
Pradl R, Stepan M (2010) Intraoperative fluid optimization using
stroke volume variation in high risk surgical patients: results of
prospective randomized study. Crit Care 14(3):R118
111. Futier E, Robin E, Jabaudon M, Guerin R, Petit A, Bazin JE,
Constantin JM, Vallet B (2010) Central venous O saturation and
venous-to-arterial CO difference as complementary tools for goal-
directed therapy during high-risk surgery. Crit Care 14(5):R193
Langenbecks Arch Surg (2011) 396:591–606 605112. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F,
Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and
gelatin on renal function in severe sepsis: a multicentre
randomised study. Lancet 357(9260):911–916
113. Schortgen F, Girou E, Deye N, Brochard L (2008) The risk
associated with hyperoncotic colloids in patients with shock.
Intensive Care Med 34(12):2157–2168
114. Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J,
Marx G, Vincent JL (2007) Effects of hydroxyethyl starch
administration on renal function in critically ill patients. Br J
Anaesth 98(2):216–224
115. Marx G, Pedder S, Smith L, Swaraj S, Grime S, Stockdale H, Leuwer
M (2004) Resuscitation from septic shock with capillary leakage:
hydroxyethyl starch (130 kd), but not Ringer's solution maintains
plasma volume and systemic oxygenation. Shock 21(4):336–341
116. Brauer A, Quintel M (2009) Forced-air warming: technology,
physical background and practical aspects. Curr Opin Anaes-
thesiol 22(6):769–774
117. Brauer A, Waeschle RM, Heise D, Perl T, Hinz J, Quintel M,
Bauer M (2010) Preoperative pre-warming as a routine measure.
First experiences. Anaesthesist 59(9):842–850
118. Park GR, Evans TN, Hutchins J, Borissov B, Gunning KE,
Klinck JR (2000) Reducing the demand for admission to
intensive care after major abdominal surgery by a change in
anaesthetic practice and the use of remifentanil. Eur J Anaes-
thesiol 17(2):111–119
119. Scatizzi M, Kroning KC, Boddi V, De Prizio M, Feroci F
(2010) Fast-track surgery after laparoscopic colorectal sur-
gery: is it feasible in a general surgery unit? Surgery 147
(2):219–226
120. Ryan D, McGreal G (2010) Why routine intensive care unit
admission after elective open infrarenal Abdominal Aortic
Aneurysm repair is no longer an evidence based practice.
Surgeon 8(6):297–302
121. Schweizer A, Khatchatourian G, Hohn L, Spiliopoulos A,
Romand J, Licker M (2002) Opening of a new postanesthesia
care unit: impact on critical care utilization and complications
following major vascular and thoracic surgery. J Clin Anesth 14
(7):486–493
122. Aguilar-Nascimento JE, Salomao AB, Caporossi C, Diniz BN
(2010) Clinical benefits after the implementation of a multimodal
perioperative protocol in elderly patients. Arq Gastroenterol 47
(2):178–183
123. Young HD, Tanga MR, Wellington JL (1971) Major abdominal
surgery in the elderly: a review of 172 consecutive patients. Can
J Surg 14(5):324–327
124. Licker M, Schweizer A, Ellenberger C, Tschopp JM, Diaper J,
Clergue F (2007) Perioperative medical management of patients
with COPD. Int J Chron Obstruct Pulmon Dis 2(4):493–515
125. Vincent JL, Burchardi H (1999) Do we need intermediate care
units? Intensive Care Med 25(12):1345–1349
126. White PF (2008) Multimodal analgesia: its role in preventing
postoperative pain. Curr Opin Investig Drugs 9(1):76–82
127. White PF, Kehlet H, Neal JM, Schricker T, Carr DB, Carli F
(2007) The role of the anesthesiologist in fast-track surgery: from
multimodal analgesia to perioperative medical care. Anesth
Analg 104(6):1380–1396
128. Kehlet H (2008) Postoperative ileus–an update on preventive
techniques. Nat Clin Pract Gastroenterol Hepatol 5(10):552–558
129. Kehlet H, Kristensen BB (2009) Local anesthetics in the surgical
wound–is the pendulum swinging toward increased use? Reg
Anesth Pain Med 34(5):389–390
130. Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005)
Malignancies, prothrombotic mutations, and the risk of venous
thrombosis. JAMA 293(6):715–722
131. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers
C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman
H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent
D, Francis CW (2007) American Society of Clinical Oncology
guideline: recommendations for venous thromboembolism pro-
phylaxis and treatment in patients with cancer. J Clin Oncol 25
(34):5490–5505
132. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen
MR, Colwell CW (2008) Prevention of venous thromboembolism:
American College of Chest Physicians Evidence-Based Clinical
Practice Guidelines (8th Edition). Chest 133(6 Suppl):381S–453S
133. Noble S, Pasi J (2010) Epidemiology and pathophysiology of
cancer-associated thrombosis. Br J Cancer 102(Suppl 1):S2–S9
134. Stanley A, Young A (2010) Primary prevention of venous
thromboembolism in medical and surgical oncology patients. Br
J Cancer 102(Suppl 1):S10–S16
135. Coleman R, MacCallum P (2010) Treatment and secondary
prevention of venous thromboembolism in cancer. Br J Cancer
102(Suppl 1):S17–S23
136. Lawrence VA, Cornell JE, Smetana GW (2006) Strategies to
reduce postoperative pulmonary complications after noncardio-
thoracic surgery: systematic review for the American College of
Physicians. Ann Intern Med 144(8):596–608
137. Cheatham ML, Chapman WC, Key SP, Sawyers JL (1995) A
meta-analysis of selective versus routine nasogastric decompres-
sion after elective laparotomy. Ann Surg 221(5):469–476,
discussion 476–468
138. Nelson R, Tse B, Edwards S (2005) Systematic review of
prophylactic nasogastric decompression after abdominal oper-
ations. Br J Surg 92(6):673–680
139. Yang Z, Zheng Q, Wang Z (2008) Meta-analysis of the need for
nasogastric or nasojejunal decompression after gastrectomy for
gastric cancer. Br J Surg 95(7):809–816
140. Buchler MW, Friess H (2006) Evidence forward, drainage on
retreat: still we ignore and drain!? Ann Surg 244(1):8–9
141. Dougherty SH, Simmons RL (1992) The biology and practice of
surgical drains. Part 1. Curr Probl Surg 29(8):559–623
142. Dougherty SH, Simmons RL (1992) The biology and practice of
surgical drains. Part II. Curr Probl Surg 29(9):633–730
143. Petrowsky H, Demartines N, Rousson V, Clavien PA (2004)
Evidence-based value of prophylactic drainage in gastrointestinal
surgery: a systematic review and meta-analyses. Ann Surg 240
(6):1074–1084, discussion 1084–1075
144. Diener MK, Mehr KT, Wente MN, Kieser M, Buchler MW,
Seiler CM (2011) Risk-benefit assessment of closed intra-
abdominal drains after pancreatic surgery: a systematic review
and meta-analysis assessing the current state of evidence.
Langenbecks Arch Surg 396(1):41–52
145. Lewis SJ, Egger M, Sylvester PA, Thomas S (2001) Early enteral
feeding versus "nil by mouth" after gastrointestinal surgery:
systematic review and meta-analysis of controlled trials. BMJ
323(7316):773–776
146. Gan TJ, Meyer TA, Apfel CC, Chung F, Davis PJ, Habib AS,
Hooper VD, Kovac AL, Kranke P, Myles P, Philip BK, Samsa G,
Sessler DI, Temo J, Tramer MR, Vander Kolk C, Watcha M
(2007) Society for Ambulatory Anesthesia guidelines for the
management of postoperative nausea and vomiting. Anesth
Analg 105(6):1615–1628
147. Lees N, Hamilton M, Rhodes A (2009) Clinical review: goal-
directed therapy in high risk surgical patients. Crit Care 13
(5):231
148. Jhanji S, Pearse RM (2009) The use of early intervention to prevent
postoperative complications. Curr Opin Crit Care 15(4):349–354
149. Singh A, Antognini JF (2010) Perioperative pharmacology in
elderly patients. Curr Opin Anaesthesiol 23(4):449–454
606 Langenbecks Arch Surg (2011) 396:591–606